Cargando…
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia
BACKGROUND: In chronic lymphocytic leukemia (CLL), changes in the peripheral blood lymphocyte subsets play an important role in disease progression and infectious complications. The impact of chemoimmunotherapy (CIT) on these changes has not been extensively studied METHODS: We used multi‐color flow...
Autores principales: | Vodárek, Pavel, Écsiová, Dominika, Řezáčová, Vladimíra, Souček, Ondřej, Šimkovič, Martin, Vokurková, Doris, Belada, David, Žák, Pavel, Smolej, Lukáš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067047/ https://www.ncbi.nlm.nih.gov/pubmed/36440594 http://dx.doi.org/10.1002/cam4.5492 |
Ejemplares similares
-
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
por: Smolej, Lukáš, et al.
Publicado: (2021) -
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
por: Šimkovič, Martin, et al.
Publicado: (2015) -
Practical approach to management of chronic lymphocytic leukemia
por: Smolej, Lukáš, et al.
Publicado: (2015) -
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
por: Šimkovič, Martin, et al.
Publicado: (2023) -
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
por: Pospiskova, Jana, et al.
Publicado: (2019)